Clinical TopicsNewsPain ManagementWeb Exclusives

FDA warns of risk of death from postop codeine use in children

Share

On Aug. 15, the U.S. Food and Drug Administration (FDA) issued a warning about risk of death from postop codeine use in children following tonsillectomy and/or adenoidectomy. The warning resulted from reports of three deaths and one life-threatening case of respiratory depression. Read more.

The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.

Take the 2024 Nursing Trends and Salary Survey, available now through November 1st 2024

See Past Results
cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

What is the primary purpose of a 3-minute foot assessment in patients with comorbidities such as diabetes or peripheral arterial disease?

More Perspectives